The present study evaluated the integration and relative value of spatial patterns of brain atrophy (SPARE-AD index), CSF biomarkers, measures of cognitive performance (ADAS-Cog), along with APOE genotype, in predicting the individual risk of converting from MCI to AD. This evidence concerns the gene APOE and Alzheimer disease.